BMJ Open Quality (Dec 2023)

Developing an electronic health record measure of low-value esophagogastroduodenoscopy for GERD at a large academic health system

  • Chi-Hong Tseng,
  • Arpan Patel,
  • John N Mafi,
  • Folasade P May,
  • Catherine Sarkisian,
  • Courtney A Reynolds,
  • Vishnu Nair,
  • Chad Villaflores,
  • Katherine Dominguez,
  • Julia Cave Arbanas,
  • Madeline Treasure,
  • Samuel Skootsky,
  • Kevin Ghassemi,
  • A Mark Fendrick

DOI
https://doi.org/10.1136/bmjoq-2023-002363
Journal volume & issue
Vol. 12, no. 4

Abstract

Read online

Objectives Low-value esophagogastroduodenoscopies (EGDs) for uncomplicated gastro-oesophageal reflux disease (GERD) can harm patients and raise patient and payer costs. We developed an electronic health record (EHR) ‘eMeasure’ to detect low-value EGDs.Design Retrospective cohort of 518 adult patients diagnosed with GERD who underwent initial EGD between 1 January 2019 and 31 December 2019.Setting Outpatient primary care and gastroenterology clinics at a large, urban, academic health centre.Participants Adult primary care patients at the University of California Los Angeles who underwent initial EGD for GERD in 2019.Main outcome measures EGD appropriateness criteria were based on the American College of Gastroenterology 2012 guidelines. An initial EGD was considered low-value if it lacked a documented guideline-based indication, including alarm symptoms (eg, iron-deficiency anaemia); failure of an 8-week proton pump inhibitor trial or elevated Barrett’s oesophagus risk. We performed manual chart review on a random sample of 204 patients as a gold standard of the eMeasure’s validity. We estimated EGD costs using Medicare physician and facility fee rates.Results Among 518 initial EGDs performed (mean age 53 years; 54% female), the eMeasure identified 81 (16%) as low-value. The eMeasure’s sensitivity was 42% (95% CI 22 to 61) and specificity was 93% (95% CI 89 to 96). Stratifying across clinics, 62 (74.6%) low-value EGDs originated from 2 (12.5%) out of 16 clinics. Total cost for 81 low-value EGDs was approximately US$75 573, including US$14 985 in patients’ out-of-pocket costs.Conclusions We developed a highly specific eMeasure that showed that low-value EGDs occurred frequently in our healthcare system and were concentrated in a minority of clinics. These results can inform future QI efforts at our institution, such as best practice alerts for the ordering physician. Moreover, this open-source eMeasure has a much broader potential impact, as it can be integrated into any EHR and improve medical decision-making at the point of care.